Aspirin resistance:a new independent predictor of vascular events?**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do no necessarily represent the views of JACCor the American College of Cardiology.
- 15 March 2003
- journal article
- editorial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 41 (6) , 966-968
- https://doi.org/10.1016/s0735-1097(02)03013-9
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular diseaseJournal of the American College of Cardiology, 2003
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Profile and prevalence of aspirin resistance in patients with cardiovascular diseaseThe American Journal of Cardiology, 2001
- The Effect of Different Antithrombotic Regimens on Platelet Aggregation After Myocardial InfarctionScandinavian Cardiovascular Journal, 1998
- Development of aspirin resistance in persons with previous ischemic stroke.Stroke, 1994
- Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patientsThrombosis Research, 1993
- Aspirin response and failure in cerebral infarction.Stroke, 1993
- Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin.Stroke, 1992
- Effects of acetylsalicylic acid in stroke patients evidence of nonresponders in a subpopulation of treated patientsThrombosis Research, 1991
- The platelet-reactivity-test — A useful “by-product” of the blood-sampling procedure?Thrombosis Research, 1991